Victoria P. Werth, MD

Dermatology
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
Schedule onlineCall 215-662-2737
Headshot of Victoria P. Werth, MD
Penn Medicine Provider

About me

  • Chief, Dermatology, Philadelphia V.A. Hospital
  • Professor of Dermatology at the Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center
  • Professor of Dermatology in Medicine

My education and training

  • Medical School: Johns Hopkins University School of Medicine
  • Residency: Northwestern Medical Center
  • Residency: New York University School of Medicine

Reviews

Average Rating

667 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
May 2026
dr. werth is knowledgeable, and she wants to see a cure for lupus. research is very important to her, and i want to be an advocate to help bring that about.
Anonymous
May 2026
dr. werth listened to all my questions & concerns and helped me figure out next steps for care
Anonymous
May 2026
great job
Anonymous
May 2026
she's not patient centered and is more focused on research

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Werth is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Murrell DF, Boucher D, Daneshpazhooh M, Mahmoudi H, Kianfar N, … Werth VP International development of Investigator Global Assessment scores for pemphigus , J Eur Acad Dermatol Venereol: 2026

Aly S, Parastandehchehr G, Bernatsky S, Vinet É, Arnaud L, Costedoat-Chalumeau N, Fortin PR, Reynolds JA, Thorne JC, Touma Z, Wallace D, Werth VP, Singer W, Mendel A A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus , J Rheumatol, 53(3): 2026,292-296

Vleugels RA, Paik JJ, Bauer Ventura I, Mangold AR, Gandiga PC, Haemel A, Chinoy H, Hussain YM, Sivakumar K, Zoltan G, Lee EB, Bozan F, Hsu CY, Femia A, Dimachkie MM, Min MS, Mozaffar T, Charles-Schoeman C, Fernandez DR, Onajin O, Marques R, Marder G, Ernste F, Schiopu E, Sluzevich J, Pearson D, Lindsey S, Luggen M, Bubb MR, Boh E, Maganti R, Heinlen L, Shaw KS, Cascino MD, Mudd PN Jr, Vencovsky J, Fernandez AP, Fiorentino D, Christopher-Stine L, Werth VP, Aggarwal R; VALOR Investigators A Phase 3 Trial of Brepocitinib in Dermatomyositis , N Engl J Med: 2026

Wei E, Lopes Almeida Gomes L, Jun S, Saksena S, Werth VP Therapeutic Approaches for Cutaneous Lupus Erythematosus: a Changing Landscape of Clinical Trials , J Inflamm Res: 2026

Khosravi-Hafshejani T, Ali H, Lopes Almeida Gomes L, Werth VP Environmental Exposures of Concern for Rheumatologists: Ultraviolet Radiation , Rheum Dis Clin North Am, 52(1): 2026,103-119

Baniel A, Momohara-Ogawa M, Bahir M, Pandya R, Kleitsch J, Chin F, Vijayarangan N, Cohen S, Johnson C, Fazelinia H, Spruce L, Werth VP Dysregulated Pathways and Potential Biomarkers in Dermatomyositis Plasma-Derived Extracellular Vesicles - A Pilot Study , J Invest Dermatol, 146(2): 2026,541-544

Korte EWH, Hiel MAJ, Bolling MC, Dunn P, Murrell DF, Werth VP, Yale M, Spuls PI, Meijer JM, Horváth B Navigating challenges in clinical trials for bulbous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert survey , Br J Dermatol, 194(1): 2026,165-167

Chambers S, Hill A, Yang X, On A, Lopes Ameida Gomes L, Khosravi-Hafshejani T, Ali H, Perez O, Bell S, Donovan C, Adjei T, Werth VP Barriers to clinical trial access among Black lupus patients , Lupus: 2025

Peters ZT, Mendyka LK, Blake J, Goswami HB, Cortez AN, Crossland GE, Shan S, Nowak EC, Mrinal S, Johann EG, Burns CM, Barton DT, Blazar BR, Curiel TJ, Mabaera R, Werth VP, Kalus A, Elkon K, Noelle RJ, Skopelja-Gardner S . Keratinocyte VISTA attenuates UV light-induced skin injury by suppressing cutaneous type I interferon (IFN-I) response , bioRxiv [Preprint]: 2025

Weiner JD, Hill A, Shen C, On A, Werth VP Identifying immunostimulatory herbal supplements that may flare autoimmune skin diseases: a systematic scoping review , Lupus Sci Med, 12(2): 2025